How marijuana contributes to weight loss — and a reduced risk of diabetes; researchers zero in on the first genes associated with postpartum depression; and ADHD in childhood may be linked to obesity later in life. These are the stories making health news this week; for more, visit TIME Health & Family.
Researchers say that a blood test may soon identify which pregnant women are at highest risk of developing postpartum depression, so they can seek treatment that could control their symptoms.
The most popular class of drugs used to treat depression, the selective serotonin reuptake inhibitors (SSRIs), may increase risk of bleeding and the need for blood transfusions following operations, according a study.
We don’t think of emotional states as passing from one person to another, but a new study suggests some depressive thoughts can go viral.
Experts say that existing screening methods can identify at-risk individuals, but such tools may not help to prevent suicides.
Exercise, Prozac and electroconvulsive therapy (ECT) may ultimately relieve depression in the same way.
Two studies explore some of the developmental roots of depression in childhood and adolescence.
Former football pros may be more likely to battle depression when they have brain damage linked to concussion
Painful experiences early in life can alter the brain in lasting ways.
It’s an anesthetic popular with vets, but the latest studies show ketamine also shows promise as a potential antidepressant.
It’s a popular cosmetic treatment, but early data hints that Botox could have a role in treating not just aging but mental illness as well.
Squabbles over two topics in particular could be especially damaging, researchers say
“What brand is your therapist?” Exploring the latest marketing trend among psychotherapists.